Clinical trials - Press Releases

Date	Title	Company
21-Aug-2020	U.S. FDA Approves Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis	Genmab A/S
21-Aug-2020	Genmab Announces Plan to Transition Arzerra® (ofatumumab) to an Oncology Access Program for Chronic Lymphocytic Leukemia Patients in the U.S.	Genmab A/S
21-Aug-2020	Genmab Announces Janssen Granted U.S. FDA Approval for DARZALEX® (daratumumab) in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma	Genmab A/S
21-Aug-2020	Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19	Pfizer and BioNTech
21-Aug-2020	Tiziana Granted a Patent on the Use of Milciclib in Combination with Tyrosine Kinase Inhibitors for Treatment of Hepatocellular Carcinoma and other Cancers	Tiziana Life Sciences plc
21-Aug-2020	Imfinzi approved in Japan for the treatment of extensive-stage small cell lung cancer	AstraZeneca PLC
21-Aug-2020	Tecan expands presence in the United States with new distribution agreement for detection instruments and consumables	Tecan
20-Aug-2020	Hercules' AhR Inhibitor HP163 Blocks Viral Replication in Zika Infection and Potentially in Covid-19	Hercules Pharmaceuticals
20-Aug-2020	Tiziana is Pleased to Retain Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board for an Additional Three-Year Term	Tiziana Life Sciences
20-Aug-2020	Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology	Ingenza
20-Aug-2020	Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD	Verona Pharma plc
20-Aug-2020	Emergex and Bio-Manguinhos/Fiocruz Elucidate T Cell Epitopes Produced by Commercial Yellow Fever Vaccine	Emergex Vaccines Holding Limited
20-Aug-2020	New links found between diabetes blood markers and Alzheimer’s disease pathology	University of Eastern Finland
20-Aug-2020	Tiziana Granted a Patent on Methods and Use of Anti-CD3 Monoclonal Antibodies for Treatment of Crohn’s Disease	Tiziana Life Sciences plc
20-Aug-2020	Intravacc's candidate RSV vaccine demonstrates safety in phase I trial	Intravacc
20-Aug-2020	Imfinzi granted FDA Priority Review for less-frequent, fixed-dose use	AstraZeneca
20-Aug-2020	The UK’s biggest innovation network extends its problem-solving prowess to “change the world”	KTN
20-Aug-2020	Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology	Amarin Corporation plc
20-Aug-2020	Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology	Amarin Corporation plc
20-Aug-2020	Kiadis collaborates with premier Dutch institutions to apply K-NK-cell technology for the development of a novel COVID-19 therapy	Kiadis Pharma N.V.